| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/02/2002 | WO2002019812A3 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 05/02/2002 | WO2002014558A3 New hydrazide building blocks and hydrazide modified biomolecules |
| 05/02/2002 | WO2002012537A3 Mutant trichosanthin |
| 05/02/2002 | WO2002010344A3 Synchronised arabidopsis cell suspensions and uses thereof |
| 05/02/2002 | WO2002008253A3 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 05/02/2002 | WO2002006460A3 Masp-2, a complement-fixing enzyme, and uses for it |
| 05/02/2002 | WO2002004523A3 Artificial antibody polypeptides |
| 05/02/2002 | WO2002002636A3 Membrane associated protein zupari |
| 05/02/2002 | WO2002000875A3 Compositions and methods for generating expression vectors through site-specific recombination |
| 05/02/2002 | WO2002000831A3 A novel polypeptide, a bromine group domain 12 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2002000830A3 A novel peptide, phosphoenolpyruvate-dependant phosphotransferase 12 and the polynucleotide coding this novel peptide |
| 05/02/2002 | WO2002000829A3 A novel peptide--- human ftsh protein 16.83 and the polynucleotide coding this novel peptide |
| 05/02/2002 | WO2002000827A3 A novel polypeptide, a dna-cysteine methyltransferase methylation protein 10 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2002000825A3 A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2002000822A3 A NOVEL POLYPEPTIDE, A HUMAIN PROTEIN SYNTHESIS INITIATION FACTOR SUB-UNIT 2 β 16.5 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 05/02/2002 | WO2001098361A3 Agonist anti-trk-c monoclonal antibodies |
| 05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 05/02/2002 | WO2001096544A3 53070, a novel human protein kinase family member and uses thereof |
| 05/02/2002 | WO2001096524A3 A novel polypeptide, a human sigma receptor 10.67 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2001096397A3 Cd154 variants and uses thereof |
| 05/02/2002 | WO2001094602A3 Method to regenerate plants and uses thereof to multiply and/or transform plants |
| 05/02/2002 | WO2001094601A3 Hero resistance gene conferring resistance to nematodes |
| 05/02/2002 | WO2001094586A3 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 05/02/2002 | WO2001094565A3 FATTY ACID ELONGASE 3-KETOACYL CoA SYNTHASE POLYPEPTIDES |
| 05/02/2002 | WO2001094529A3 A novel polypeptide, a human atp dependant serine proteinase 21 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2001092495A3 A human lysyl ixodase (47765) and uses thereof |
| 05/02/2002 | WO2001092301A3 Placc, a novel human c-c chemokine isolated from placenta |
| 05/02/2002 | WO2001091803A3 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 05/02/2002 | WO2001090147A3 Long wavelength engineered fluorescent proteins |
| 05/02/2002 | WO2001087932A3 Seven transmembrane proteins and polynucleotides encoding the same |
| 05/02/2002 | WO2001083790A3 Plant regulatory sequences for selective control of gene expression |
| 05/02/2002 | WO2001083770A3 Lipolytic enzyme variant |
| 05/02/2002 | WO2001083710A3 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 05/02/2002 | WO2001083555A3 Pain signaling molecules |
| 05/02/2002 | WO2001081582A3 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001075166A3 Compositions and methods for detecting and quantifying gene expression |
| 05/02/2002 | WO2001074900A3 Nuclear factor kb inducing factor |
| 05/02/2002 | WO2001073048A3 Pi3k - regulatory subunit homology |
| 05/02/2002 | WO2001072778A3 Method of identifying inhibitors of tie-2 |
| 05/02/2002 | WO2001070951A3 Agent for the diagnosis and therapy of viral diseases |
| 05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
| 05/02/2002 | WO2001069244A3 Method for labeling individual cells |
| 05/02/2002 | WO2001068824A3 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 05/02/2002 | WO2001068708A3 Human and humanized fap-alpha-specific antibodies |
| 05/02/2002 | WO2001066772A3 Heparinase iii and uses thereof |
| 05/02/2002 | WO2001066759A3 26886, a novel carnitine acyltransferase family member and uses therefor |
| 05/02/2002 | WO2001066242A3 Device and method for performing syntheses, analyses or transport processes |
| 05/02/2002 | WO2001066150A3 Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles |
| 05/02/2002 | WO2001064926A3 Methods and compositions to reduce or eliminate transmission of a transgene |
| 05/02/2002 | WO2001064882A3 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor |
| 05/02/2002 | WO2001064875A3 Human transporter genes and proteins encoded thereby |
| 05/02/2002 | WO2001064873A3 Human gtpase activator proteins |
| 05/02/2002 | WO2001064749A3 Method for preparing anti-mif antibodies |
| 05/02/2002 | WO2001062931A3 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 05/02/2002 | WO2001062923A3 Transporters and ion channels |
| 05/02/2002 | WO2001061009A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001059450A3 Cells expressing zinc finger protein for drug discovery |
| 05/02/2002 | WO2001055708A3 Method of processing a sample containing at least one biological element |
| 05/02/2002 | WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 05/02/2002 | WO2001055314A3 Digestive system related nucleic acids, proteins and antibodies |
| 05/02/2002 | WO2001055210A3 Human cyr61 |
| 05/02/2002 | WO2001051635A3 Novel stra6 polypeptides |
| 05/02/2002 | WO2001048209A3 Genes identified as required for proliferation of e. coli |
| 05/02/2002 | WO2001048185A3 Transcription regulatory sequences derived from chlamydomonas reinhardtii |
| 05/02/2002 | WO2001046394A3 Mammalian protein phosphatases |
| 05/02/2002 | WO2001042494A3 Test system for detecting analytes, a method for the production thereof and its use |
| 05/02/2002 | WO2001040301A3 A gene, disrupted in schizophrenia |
| 05/02/2002 | WO2001036979A3 Placental human neurokinin b precursor |
| 05/02/2002 | WO2001036617A3 Assay for measuring enzyme activity in vivo |
| 05/02/2002 | WO2001036586A3 Aspegillus niger beta-glucosidase gene, protein and uses thereof |
| 05/02/2002 | WO2001034824A3 Methods and compositions comprising renilla gfp |
| 05/02/2002 | WO2001034767A3 22 human secreted proteins |
| 05/02/2002 | WO2001032935A3 Molecular microarrays and methods for production and use thereof |
| 05/02/2002 | WO2001031028A3 Mutant luciferase |
| 05/02/2002 | WO2001029071A3 Genes associated with obesity and methods for using the same |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001027292A3 Methods and compositions for targeting a cell |
| 05/02/2002 | WO2001019482A3 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001018061A3 Maize polynucleotides and related polypeptides useful for enhancing disease resistance in crop plants |
| 05/02/2002 | WO2001016378A3 Chromosome-wide analysis of protein-dna interactions |
| 05/02/2002 | WO2001011068A3 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 05/02/2002 | WO2001009381A3 Methods of nucleic acid analysis by detecting molecular binding events |
| 05/02/2002 | WO2001007665A3 Sequence determination of nucleic acids using electronic detection |
| 05/02/2002 | WO2001007651A3 Transposon mediated differential hybridisation |
| 05/02/2002 | WO2001000874A3 Cancer associated antigens and uses therefor |
| 05/02/2002 | WO2001000237A9 Synthetic peptide immunogens and antibodies thereto |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000078960A9 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/02/2002 | WO2000077208A9 Gustatory receptors in drosophila |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | WO2000047771A3 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism |
| 05/02/2002 | WO2000044395A9 Methods and compositions for modulating fertility |
| 05/02/2002 | WO2000042219A9 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| 05/02/2002 | WO1999058683A9 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
| 05/02/2002 | US20020053099 New plants formed by microparticle bombardment with uncharacterised DNA |
| 05/02/2002 | US20020053098 Nucleotide sequences coding enzymatic polypeptide for use in generating poison resistant plants |
| 05/02/2002 | US20020053097 Seeds for the generation of crop plants for use in bioremediation, medicine development and making alcoholic beverages |